miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
about
miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@en
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@nl
type
label
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@en
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@nl
prefLabel
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@en
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@nl
P2093
P2860
P1433
P1476
miR-429 suppresses tumor migra ...... helial-mesenchymal transition.
@en
P2093
Chunmei Guo
Dongting Zhao
Ming-Zhong Sun
Qiuling Zhang
Shuqing Liu
P2860
P356
10.1038/S41598-018-20258-8
P407
P577
2018-02-05T00:00:00Z